【摘要】 目的探讨单病种质量控制在急性脑梗死应用中的作用。方法选择2011年9月~2013年8月实行单病种质量控制后的急性脑梗死患者76例(质控后组),另选2008年9月~2010年8月尚未实行单病种质量控制的急性脑梗死患者67例(质控前组),对2组48h内抗栓治疗、调脂治疗、康复实施、住院总费用、药费占比、住院日和神经功能缺损评分等7个方面进行比较。结果质控后组调脂治疗比例较质控前组明显升高(90.8%vs 52.2%,P<0.01),住院总费用[(16659.90±9775.62)元vs(19957.17±8712.93)元]、药费占比[(48.94±10.46)%vs(52.45±9.85%)]、住院日[(14.49±7.76)d vs(17.16±8.23)d]较质控前组明显降低(P<0.05)。2组抗栓治疗、康复实施比例和神经功能缺损比较,差异无统计学意义(P>0.05)。结论实行单病种质量控制能有效降低住院费和药费占比,缩短住院日,提高医师对急性脑梗死调脂治疗的重视,值得在临床推广应用。更多还原

【Abstract】 Objective To study the application of quality control of single disease in acute ischemic stroke(AIS)patients.Methods Seventy-six AIS patients who underwent quality control of single disease served as a post-quality control group and 67 AIS patients who did not underwent quality control of single disease served as a pre-quality control group.Their antithrombotic therapy within 48 h,lipid-regulating therapy,rehabilitation therapy,hospital cost,medication ratio,hospital stay days and neurological defect score were compared.Results The lipid-regulating therapy ratio was significantly higher while the total hospital cost and medication ratio were significantly lower and the hospital stay days were significantly less in post-quality control group than in pre-quality control group(90.8%vs 52.2%,P<0.01;16659.90±9775.62 RMB yuan vs 19957.17±8712.93 RMB yuan,48.94%±10.46%vs 52.45%±9.85%,14.49±7.76 days vs 17.16±8.23 days,P<0.05).No significant difference was found in antithrombotic therapy within 48 h,rehabilitation therapy and neurological defect score between the two groups(P>0.05).Conclusion Quality control of single disease can effectively reduce the hospital cost,medication ratio and hospital stay time of AIS patients,and is thus worthy of popularization in clinical practice.更多还原